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Abstract Nuclear envelope-peripheral heterochromatin frac-
tions contain multiple histone kinase activities. In vitro assays
and amino-terminal sequencing show that one of these activities
co-isolates with heterochromatin protein 1 (HP1) and phosphor-
ylates histone H3 at threonine 3. Antibodies recognizing this
post-translational modi¢cation reveal that in vivo phosphoryla-
tion at threonine 3 commences at early prophase in the vicinity
of the nuclear envelope, spreads to pericentromeric chromatin
during prometaphase and is fully reversed by late anaphase.
This spatio-temporal pattern is distinct from H3 phosphoryla-
tion at serine 10, which also occurs during cell division, suggest-
ing segregation of di¡erentially phosphorylated chromatin to
di¡erent regions of mitotic chromosomes.
) 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
A signi¢cant proportion of heterochromatin is located at
the periphery of the cell nucleus, in close proximity to the
nuclear envelope (NE) [1]. This spatial association, which re-
£ects a multiplicity of interactions between integral proteins of
the inner nuclear membrane and components of chromatin
(e.g. heterochromatin protein 1 (HP1), barrier to autointegra-
tion factor, etc. ; see [2,3]), could be interpreted in two di¡er-
ent ways. First, peripheral heterochromatin may possess spe-
ci¢c epigenetic modi¢cations that dictate NE association
(reviewed in [4,5]). Alternatively, domains of non-condensed
chromatin could be subjected to ‘heterochromatinization’
when brought to the vicinity of the NE [6].
NE^chromatin interactions are also relevant to mitotic
events. At prophase, condensing chromosomes come into in-
timate contact with the nuclear surface. Interestingly, the con-
densation process is not completed until the NE is ruptured
and the chromosomes are ‘stripped’ of membrane remnants
by mitotically activated microtubule-based motors [7,8].
Both heterochromatin formation and chromosome conden-
sation involve histone modi¢cations and recruitment of spe-
ci¢c regulatory factors [9^12]. One of the most thoroughly
analyzed modi¢cations is the phosphorylation of histone
H3. The H3 molecule is phosphorylated at four di¡erent sites,
serines 10/28 and threonines 3/11, all located at its N-terminal
tail. Serine 10 phosphorylation during interphase is catalyzed
by the RSK-2 and MSK-1 kinases that are induced by mito-
genic and stress signals, respectively [13^16]. Mitotic phos-
phorylation at serines 10 and 28 is mediated by Aurora B
kinase ([17^20]; reviewed in [16]), which has close homologues
in yeast (Ipl1/AIR-2) and Aspergillus nidulans (NIMA).
Threonine 11 phosphorylation also occurs during mitosis
and involves the Dlk/ZIP kinase, a member of the DAP fam-
ily [21]. In addition to H3, this enzyme modi¢es histones H4,
H2A and the myosin light chain in vitro. Finally, H3 phos-
phorylation at threonine 3 is mediated by a non-characterized
kinase [22,23].
Using NE-associated, peripheral heterochromatin fractions
as a source, we have found that the threonine 3-speci¢c kinase
activity co-isolates with HP1 and mediates mitotic modi¢ca-
tion of histone H3 in a spatio-temporal pattern that is distinct
from that of serine 10 phosphorylation.
2. Materials and methods
2.1. Antibodies
The anti-M31 rat monoclonal antibody MAC 353 has been de-
scribed in [24]. Anti-phospho-histone H3 (Ser10) rabbit polyclonal
and mouse monoclonal antibodies were purchased from Upstate Bio-
technology (Lake Placid, NY, USA).
2.2. Cell fractionation
NE vesicles were prepared from turkey erythrocyte nuclei, essen-
tially as speci¢ed in [25,26] with slight modi¢cations and further
puri¢ed in £otation gradients (70-50-30-20% sucrose cushions;
100 000Ug, 18 h, 4‡C), collecting the 50^30% interface. Extracts
were prepared by thorough resuspension of NE vesicles or sonicated
‘nuclear ghosts’ (NGs) in 300^600 mM NaCl, 20 mM Tris^HCl pH
7.5, 260 mM sucrose, 2 mM MgCl2, 0.1 mM EGTA, 1 mM dithio-
threitol (DTT), 1 mM phenylmethylsulfonyl £uoride (PMSF), pro-
tease inhibitors, plus or minus 1% Triton X-100 (bu¡ers S and ST,
respectively). After ultracentrifugation (200^350 000Ug, 30 min, 4‡C),
the soluble extracts (SE and STE, respectively) were collected and
either used immediately, or further fractionated in 5^20% sucrose
density gradients (100 000Ug, 18 h, 4‡C).
2.3. Microscopy
For light microscopy, samples were ¢xed with 1% formaldehyde in
phosphate-bu¡ered saline, permeabilized with 0.2% Triton X-100 and
blocked with 1% ¢sh skin gelatin according to [27].
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2.4. Assays
Glutathione S-transferase (GST) fusion proteins were immobilized
to glutathione-agarose beads, mixed with the extracts and incubated
for 1 h at room temperature. The beads were washed ¢ve times with
bu¡er ST and once with bu¡er I (150 mM NaCl, 20 mM Tris^HCl
pH 7.5, 2 mM MgCl2, 260 mM sucrose, 0.1 mM EGTA, 1 mM DTT,
1 mM PMSF). To assess histone H3 phosphorylation, 2 WCi of
[Q-32P]ATP (speci¢c activity: 9000 Ci/mmol) was added to M31-
GST precipitates resuspended in bu¡er I. The reaction mixture was
incubated for 1 h at room temperature and the products were ana-
lyzed by sodium dodecyl sulfate^polyacrylamide gel electrophoresis
(SDS^PAGE) and autoradiography.
2.5. Other methods
N-terminal sequencing and Western blotting were done according
to standard procedures. For core particle depletion 2 ml of the S1
fraction was mixed with 0.3 ml CM-cellulose and the unbound frac-
tion (S2) collected. Enzyme-linked immunosorbent assays (ELISA)
were performed as described in [28].
3. Results and discussion
To identify enzyme activities associated with peripheral
structures of the cell nucleus, we prepared NGs and NE
vesicles from avian erythrocytes [25,26,29]. Sub-fractionation
by £otation in sucrose gradients yielded fragments of periph-
eral heterochromatin that were tightly associated with the NE
(NEPH fraction; details of these methods and mass spectro-
metric data to be published elsewhere).
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Fig. 1. Identi¢cation of a histone H3 kinase activity. A: In vitro
phosphorylation assay using the whole NEPH fraction. Lane CB
shows a SDS^PAGE/Coomassie blue pro¢le of the preparation;
lane AR is the corresponding autoradiogram after incubation with
[32P]ATP. LBR and histones H5/H3 are indicated. B: Pull-down/in
vitro phosphorylation assay using a salt/Triton extract of NEPH
(STE). The extract was incubated with immobilized GST (lanes 1),
or M31-GST (lanes 2, 3). The material precipitated was then incu-
bated with [32P]ATP (lanes 1, 2), or a mixture of [32P]ATP and (ex-
cess) cold ATP (lanes 3). The products were analyzed by SDS^
PAGE (CB) and autoradiography (AR). The position of histone H3
is indicated. C: Pro¢le of DNA co-precipitated with histone oc-
tamers under the conditions described in B. Lane 1: GST precipi-
tate; lane 2: M31-GST precipitate. Numbers to the right correspond
to bp. An ethidium bromide (EtBr)-stained agarose gel is shown.
Due to extensive DNase I digestion during preparation of NGs the
average size of DNA is about 150 bp. D: Partitioning of the H3 ki-
nase activity under in vitro conditions. The panel shows a NEPH
salt extract (SE) fractionated in linear 5^20% sucrose gradients and
analyzed by SDS^PAGE. The relevant area of the core histones is
shown. The top and bottom of the gradient are indicated. E: M31-
GST pull-down/in vitro phosphorylation assay (as in B) using suc-
cessive gradient fractions (from 1 to 16). As explained in the text, a
small amount of exogenous histones was added to all fractions prior
to incubation with [32P]ATP. Lane CB shows the area of M31-GST
and core histones from a Coomassie blue-stained gel; lane AR is
the corresponding autoradiogram in the area of the core histones.
Fractions exhibiting the highest kinase activity are denoted by ar-
rows, while the peak of core particles is indicated by dots. F: Prep-
aration of core particle-depleted extracts. SDS^PAGE pro¢les of the
initial extract (SE); supernatant after dilution of SE with water and
ultracentrifugation (S1); and £owthrough after passing S1 through a
(small amount) of CM-cellulose (S2). For details see text and Sec-
tion 2. G: Pull-down/in vitro phosphorylation assay using the S2
fraction. All samples have received labeled ATP. Lanes 1: pull-
down with M31-GST; lanes 2: GST control; lanes 3, 4: same as 1,
2 after addition of exogenous core histones prior to incubation with
labeled ATP; lanes 5, 6: mock experiments (no M31-GST or S2, re-
spectively, added to the reaction mixture). Lane CB indicates a
Coomassie blue-stained gel and lane AR the corresponding autora-
diogram. H: Identi¢cation of the H3 phosphorylation site. The sin-
gle 32P-labeled band shown in B was excised with the aid of an
autoradiogram and subjected to N-terminal sequencing. Radioactiv-
ity released after each Edman degradation step and counts remain-
ing in the sample at the end of the procedure were measured by
L-counting. Of the 30 N-terminal residues determined, amino acids
9 and 27 were blocked (Xs, signi¢ed by dots).
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When NEPHs were incubated with [32P]ATP, three poly-
peptides with the electrophoretic mobility of histone H5, his-
tone H3 and the lamin B receptor (LBR) were reproducibly
phosphorylated (Fig. 1A). Phosphorylation of LBR is known
to be catalyzed by a serine-arginine (SRPK1) kinase [30,31] ;
however, the phosphorylation of histones H5 and H3 could be
attributed to a variety of cAMP-dependent and cAMP-inde-
pendent protein kinases present in nucleated erythrocytes [32].
To enrich for histone H3-speci¢c kinases, we took advan-
tage of the fact that histone H3 binds to HP1 and associated
enzymes (e.g. Suvar3, 9) under stringent in vitro conditions
[33^35]. To this end, NEPHs were extracted with detergent/
high salt and the soluble extracts (STE; Fig. 1B) used for pull-
down experiments (immunoprecipitation with anti-HP1 anti-
bodies was not considered because avian erythrocytes possess
relatively small amounts of endogenous HP1) [36,37]. Data
depicted in Fig. 1B,C show that recombinant mouse HP1L
(M31-GST) co-precipitated core particles and a kinase activity
(T3K) that apparently phosphorylated histone H3.
To distinguish whether T3K was associated with M31 or
nucleosomes, we fractionated salt extracts of NEPHs (SEs; no
Triton X-100 included in the bu¡er to avoid co-extraction of
integral membrane proteins such as LBR and associated ki-
nases) in sucrose gradients (Fig. 1D). The gradient fractions
were combined with immobilized M31-GST and the com-
plexes formed incubated with [32P]ATP. To compensate for
the fact that the top fractions of the gradient did not contain
visible quantities of core histones, a small amount of exoge-
nous octamers was added to all samples at the beginning of
the incubation. Results presented in Fig. 1E show clearly that
fractions containing nucleosomes did not possess T3K activ-
ity.
To examine the alternative possibility, i.e. that T3K asso-
ciates with M31, we performed pull-down experiments using
nucleosome-depleted extracts. To remove chromatin particles,
the original SE extract was diluted with water (to lower the
NaCl concentration) and ultracentrifuged. In pilot experi-
ments we have found that this ‘salt shift’ renders the bulk
of the core particles pelletable, without a¡ecting other constit-
uents of the preparation. This partially depleted extract (S1
fraction shown in Fig. 1F) was passed through a CM-cellulose
column to remove traces of histones (both core and linker; for
details see Section 2). Finally, the CM-cellulose £owthrough
(S2), adjusted again at high salt, was incubated with M31-
GST and used for in vitro phosphorylation assays. As shown
in Fig. 1G, no labeling of histone H3 was detected when the
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Fig. 2. Characterization of the anti-phosphothreonine 3 antibodies.
A,B: Western blot analysis. Ip, Mp: insoluble pellets after homoge-
nization of interphase and nocodazole-arrested C127 cells, respec-
tively; Is, Ms: the corresponding supernatants. CB and Blot show a
Coomassie blue-stained gel and the corresponding Western blot. C:
ELISA. Di¡erent amounts of the antigenic peptide (closed squares)
or recombinant H3 (closed circles) were probed by rabbit anti-phos-
phothreonine 3 antibodies. The OD495 values as a function of the
antigen concentration are shown in the graph. D,E: Indirect immu-
no£uorescence assay using the anti-phosphothreonine 3 antibodies
(anti-PT3), or a mixture of the antibodies and the antigenic peptide,
as indicated. The specimens were counterstained with DAPI and
photographed at low power in a conventional £uorescence micro-
scope. Arrows point to anaphase or telophase cells. Mitotic ¢gures
from prophase to early anaphase are positive, while late anaphase,
telophase and interphase cells are negative.
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material precipitated from depleted extracts was incubated
with [32P]ATP, or when the experiment was performed in a
mock fashion (omitting S2 or M31-GST). However, robust
H3 phosphorylation was observed if exogenous core histones
were combined with the M31-GST precipitate before addition
of [32P]ATP. Taken together with the previous results, these
data demonstrate that T3K associates speci¢cally with M31
under in vitro conditions.
Determination of the histone H3 phosphorylation site was
accomplished by N-terminal sequencing. The bulk (ca. 90%)
of radioactivity was released in the ¢rst 10 Edman degrada-
tion steps and 32P peaked at amino acid 3 (a threonine; Fig.
1H). No other peaks in the N-terminal sequence, or the C-ter-
minal segment of histone H3 were detected, but we did notice
‘trailing’ of 32P in residues 4 and 5 (a lysine and a glutamine,
respectively) in both microsequencing attempts we made. This
seems to be a common shortcoming of the technique (see also
[38^40]) and can be explained by non-speci¢c sticking of
cleaved material to adjacent residues. Interestingly, the N-ter-
minal sequence of histone H3 was ‘blocked’ in two positions
(Fig. 1G, residues denoted by Xs). This is in line with mass
spectrometry and immunohistochemical data which indicate
that NEPH-associated chromatin, being largely heterochro-
matic, is extensively methylated at lysines 9 and 27 (our un-
published observations; see also [37]).
To examine the in vivo signi¢cance of H3 phosphorylation,
we raised polyclonal antibodies using as an antigen a synthetic
histone H3 peptide (15-mer) phosphorylated at threonine 3. In
Western blots the antibodies reacted strongly with mitotically
modi¢ed histone H3, but gave only a background signal with
interphase H3 (Fig. 2A,B). ELISAs con¢rmed that the anti-
bodies were of high a⁄nity and did not react with recombi-
nant (i.e. unmodi¢ed) histone H3 (Fig. 2C).
Indirect immuno£uorescence showed that threonine 3-spe-
ci¢c phosphorylation occurs only during the early phases of
mitosis (Fig. 2D,E). The distribution of threonine 3-phosphor-
ylated histone H3 was very similar to that reported for threo-
nine 11-phosphorylated H3 [21]. However, examination of
mitotic cells by confocal microscopy revealed a signi¢cant
di¡erence between serine 10- and threonine 3-speci¢c H3
phosphorylation. During late anaphase and telophase no
staining with anti-phosphothreonine 3 antibodies could be
discerned, while phosphoserine 10-histone H3 was clearly de-
tectable at the periphery of chromosome packages and re-
forming nuclei (Fig. 3A,B, anaphase and telophase). Further-
more, although both modi¢cations appeared to commence at
areas of prophase chromosomes neighboring with the NE
(Fig. 3A,B, prophase), upon progression of mitosis the two
signals became distinct : threonine 3-phosphorylated H3 was
more concentrated in the central region of the metaphase
plate and extended to chromosome arms, while serine 10-
phosphorylated H3 was more prominent in the periphery of
the metaphase plate (Fig. 3A,B, prometaphase and meta-
phase).
Double labeling with anti-phosphoserine 10 and phospho-
threonine 3 antibodies was not feasible for technical reasons.
Nonetheless, double immuno£uorescence with anti-phos-
phoH3 and CREST antibodies showed that threonine 3- and
serine 10-speci¢c phosphorylation did not involve centromeric
foci (Fig. 4B, panels prophase). The rim-£uorescence pattern
of serine 10 phosphorylation in prophase cells was much more
uniform than the pattern of threonine 3 phosphorylation (Fig.
4A,B, prophase; see also Fig. 3). Upon progression of mitosis,
threonine 3 phosphorylation spread to the chromosome arms
and pericentromeric chromatin, whereas serine 10 phosphor-
ylation was focused at the distal segments of the chromosomes
and was much less in other points (Fig. 4B, metaphase).
Consistent with previous observations [17], double labeling
Fig. 3. Comparison of threonine 3- and serine 10-speci¢c phosphor-
ylation during mitosis. A: Immunostaining of C127 cells with anti-
phosphothreonine 3-speci¢c antibodies (anti-PT3). B: Immunostain-
ing of C127 cells with anti-phosphoserine 10-speci¢c antibodies
(anti-PS10). The phases of mitosis are indicated on the left. For
early prophase, prometaphase and metaphase two di¡erent confocal
sections (one equatorial and one more tangential) are shown. The
specimens were counterstained with propidium iodide (PI). For
clarity, merged images have been slightly magni¢ed in relation to in-
dividual sections.
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with anti-M31 and anti-phospho H3 antibodies showed that
serine 10 phosphorylation begins in the G2 phase around
heterochromatic foci containing M31 (Fig. 4A, G2). At this
point, a £uorescence signal with anti-phosphothreonine 3 anti-
bodies could not be discerned (see also Fig. 2D). Finally, in
prophase cells, threonine 3- and serine 10-phosphorylated H3
were distributed di¡erently from M31, which exhibited a dif-
fuse nucleoplasmic £uorescence (Fig. 4A, prophase). From
this it can be concluded that M31 no longer associates with
any of the two phosphorylated histone H3 species during
mitosis.
A protein kinase that phosphorylates threonine 3 of histone
H3 in vitro has been previously identi¢ed in bovine thymus
nuclei by Shoemaker and Chalkley [22,23]. Using more re¢ned
methods and material we have extended these ¢ndings, dem-
onstrating that threonine 3 phosphorylation occurs in vivo.
Due to the scarcity of material we have not been able to
purify T3K and study directly its distribution. However,
from the currently available data there are strong indications
that this enzyme is tightly associated with peripheral struc-
tures of the cell nucleus: (1) threonine 3 phosphorylation dur-
ing early prophase clearly initiates in the neighborhood of the
NE; (2) the H3 kinase activity can be detected in highly pu-
ri¢ed NEPH preparations; (3) T3K associates with HP1, a
heterochromatin-speci¢c protein known to interact with the
NE [41^43].
The patterns of threonine 3 and threonine 11 phosphoryla-
tion clearly di¡er from that of serine 10 phosphorylation ([21]
and this report). Interestingly, all three modi¢cations com-
mence at chromosomal regions attaching to the NE during
prophase, but ‘focus’ quickly on di¡erent territories. This
would suggest that ‘waves’ of phosphorylation and dephos-
phorylation sweep over the chromosomes at early phases of
mitosis and create zones containing di¡erent forms of phos-
phorylated H3. The alternative explanation, i.e. that anti-
phosphoserine and anti-threonine antibodies do not have ac-
cess to the same territories of metaphase chromosomes (be-
cause the corresponding epitopes are di¡erentially masked) is
not as likely: a variety of experiments that we have performed
using di¡erent sample preparation and ¢xation conditions
con¢rm that threonine 3 and serine 10 phosphorylated histone
H3 species are always distributed in di¡erent areas of mitotic
chromosomes (data not shown).
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